This Little Pink Pill Can Help Boost Your Libido—and It Was Just FDA-Approved for Postmenopausal Women
NewBeauty Facebook Pinterest Instagram Youtube find a doctor Face Adult Acne Antioxidants Anti-Aging Celebrity Chronic Skin Conditions Eye Hydration Hyperpigmentation Makeup View All Eyebrows Eye Color Foundation Fragrance Lip Color Makeovers Male Skin Care Peels Pre-Event Prep Sensitive Skin Skin Care Skin Health Smile Sun Care Treatments Fillers Microneedling Post-Procedure Skin Care Neurotoxins Regenerative Aesthetics Skin Lifting Body Body Sculpting Breasts Butts Cellulite Hair Removal Hands + Nails Legs Pregnancy Find a Doctor Hair Bond Repair Celebrity Dry Hair Frizzy Hair Gray Hair Hair Color Hair Growth Hair Repair Scalp Health Styling + Tips Awards NB100 Awards 15th Annual Beauty Awards 2025 NewBeauty Readers’ Choice Awards Shopping Gift Guides Product Reviews NewBeauty Storefront Wellness Fitness GLP-1s Health Menopause About Us TESTTUBE Search for: Search HomeWellness This Little Pink Pill Can Help Boost Your Libido—and It Was Just FDA-Approved for Postmenopausal Women Finally, there's an option for women. Allie Hogan Updated: Dec 15, 2025 Photo by BAILEY MAHON on Unsplash We’ve all heard about the little blue pill (Viagra), but are you familiar with a product for women that has the same special powers? Meet Addyi—daily pill to help increase sexual desire in women from Sprout Pharmaceuticals, helmed by Cindy Eckert. Addyi has been FDA approved for treatment in premenopausal women since August 2015. On December 15, 2025 the FDA also approved Addyi for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in postmenopausal women under 65 years of age. This landmark decision helps further close the gap between men and women’s sexual healthcare. Throughout her career Eckert had helped build a male sexual health company, then looked around and realized that while there were 26 FDA-approved options for men, there were zero for women. The new documentary The Pink Pill: Sex, Drugs and Who Has Control dives into the gender bias…